Kimberly C Banks

10PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study.

Samantha I Liang, Zoe Quandt, Sara Wienke

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Aug 25, 2022
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer.

James T Topham, Chris J O'Callaghan, Harriet Feilotter

|Jul 17, 2021
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

Belinda Kingston, Rosalind J Cutts, Hannah Bye

|Apr 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNA.

Belinda Kingston, Rosalind J Cutts, Hannah Bye

|Dec 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.

Han Si, Michael Kuziora, Katie J Quinn

Pageof 2

Frequent Collaborators

5 joint publications

Richard B Lanman

2 joint publications

Jonathan M Loree

2 joint publications

Hagen F Kennecke

2 joint publications

Lucy S Kilburn